Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Bullboard Posts
Post by PoorOpinionon Jul 20, 2018 6:24pm
190 Views
Post# 28347253

Something for chinese speakers

Something for chinese speakers1) This video seems to be an investor meeting for Taimed(?????) . Is it, is it something recent or those meetings from a month or two ago? Is there anything new in it?

https://m.youtube.com/watch?t=24s&v=ZvueQlpX0wc

2) This taiwanese BB post seems to be notes from somebody attending a Taimed investor meeting. It seems to suggest Taimed's explanation for the discrepancy between their patient numbers (300) and theratechnologies (200) came from the delay that occurs between patients getting into the process and starting the drug. It seems Taimed may have jumped the gun in counting some people earlier than Thera. Counting chickens before they hatch, would make sense. Also seems to suggest taimed are now referring people to thera to answer these questions. Again is this from a very recent meeting?
JackJimmy

Agenda

Jack

()





TH7 TH (?)

TH ( xd)

TMB-355TH

Q&A.....()

Peter Kurz



R&D pipe line

TH ()

TH. .... ()

TH

TMB355(learning curve )

TMB-3554-6

PRO 140pipe line Phase 3










Bullboard Posts